Liminal BioSciences Inc. Common Shares
LMNL
LMNL was delisted on the 25th of September, 2023.
1 hedge funds and large institutions have $0 invested in Liminal BioSciences Inc. Common Shares in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 7 closing their positions.
88% less funds holding
Funds holding: 8 → 1 (-7)
100% less capital invested
Capital invested by funds: $108K → $0 (-$108K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$61.1K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$21.2K |
| 3 |
Morgan Stanley
New York
|
-$10.7K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.49K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$61.1K | -9,852 | Closed |
|
|
FDCDDQ
2
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$21.2K | -3,377 | Closed |
|
|
3
Morgan Stanley
New York
| – | -$10.7K | -1,706 | Closed |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$7K | -1,039 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$4.49K | -715 | Closed |
|
|
ECM
6
Estabrook Capital Management
New York
| – | -$3.14K | -500 | Closed |
|
|
TWC
7
TD Waterhouse Canada
Toronto,
Ontario, Canada
| – | -$25 | -3 | Closed |
|
LMNL Hedge Fund Activity: Q3 2023 in Review
1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q3 2023, worth a combined $0 — down 100% from $108K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of LMNL and 0 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was National Bank of Canada, exiting entirely with an estimated $61.1K sold.
- 1 institutional investor held Liminal BioSciences Inc. Common Shares (LMNL) as of Q3 2023, down from 8 in Q2 2023.
- Funds reported $0 of Liminal BioSciences Inc. Common Shares stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Liminal BioSciences Inc. Common Shares positions in Q3 2023 and 7 closed out, a net change of -7 holders.
- The largest Liminal BioSciences Inc. Common Shares seller in Q3 2023 was National Bank of Canada, an estimated $61.1K sold.
Based on aggregated 13F filings for Q3 2023.